RT Book, Section
A1 Shinkai, Kanade
A1 Fox, Lindy P.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
SR Print(0)
ID 1175804635
T1 Reactive Erythemas
T2 Current Medical Diagnosis & Treatment 2021
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260469868
LK accessmedicine.mhmedical.com/content.aspx?aid=1175804635
RD 2022/05/24
AB Key  Clinical  Updates  in  Reactive  ErythemasLigelizumab  is  effective  for  chronic  urticaria  in  early  clinical  trials.Etanercept  is  emerging  as  a  promising  therapy  for  Stevens-Johnson  syndrome/toxic  epidermal  necrolysis  and  is  now  the  treatment  of  choice  in  some  centers.